Home BioCryst Pharmaceuticals Price Target Lowered to $10.00 at Jefferies Group
 

Keywords :   


BioCryst Pharmaceuticals Price Target Lowered to $10.00 at Jefferies Group

2015-10-18 09:44:56| Biotech - Topix.net

The firm presently has a "hold" rating on the biotechnology company's stock. Jefferies Group's price objective would indicate a potential upside of 13.12% from the stock's previous close.

Tags: price group target lowered

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
More »